SCHEMBL5407428

SCHEMBL5407428

Cn1c(=O)c2c(Br)[nH]nc2n(CC2CC2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 11/20 0.45
PDE4D Q08499 11/20 0.45
PDE4A P27815 10/20 0.45
PDE4B Q07343 10/20 0.45
PDE4C Q08493 10/20 0.45
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
ADORA1 P30542 2/20 0.39
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
PDE2A O00408 1/20 0.36
PDE1B Q01064 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
PARG Q86W56 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5395202 0.79 PDE1A (0.50) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL5403546 0.72 PDE5A (0.45) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL25211015 0.66 PDE5A (0.56) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL21602439 0.65 PDE4D (0.55) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL19210142 0.64 PDE4A (0.68) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL10333914 0.63 ADORA2A (0.48) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL7809025 0.63 PDE4A (0.70) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL25235156 0.63 PDE5A (0.60) PDE5APDE4DPDE4APDE4BPDE4C
SCHEMBL5935785 0.62 ADORA2A (0.60) PDE4DPDE4APDE4BPDE4CPOLB
SCHEMBL7400872 0.62 PDE5A (1.00) PDE5APDE4DPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285558-B2 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections ASTRAZENECA AB (SE) 2007-10-23 US disclosed
US-7285558-B2 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections ASTRAZENECA AB (SE) 2007-10-23 US disclosed
US-7285558-B2 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections ASTRAZENECA AB (SE) 2007-10-23 US disclosed
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections ASTRAZENECA AB (SE) 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254183-A1 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections DPYD, HPGDS, PGC PDE5A 933/4885PDE4D 1325/4885PDE4A 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.